Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the effects of subcutaneous omalizumab versus placebo for asthma in adults and children.

Original publication

DOI

10.1002/14651858.CD014975

Type

Journal article

Journal

Cochrane Database of Systematic Reviews

Publication Date

22/07/2021

Volume

2021